Skip to main content
Premium Trial:

Request an Annual Quote

Inproteo Licenses His Tag Patent to Pierce Biotechnology

NEW YORK, Oct. 29 (GenomeWeb News) - Inproteo, the organization previously known as the Indiana Proteomics Consortium, has licensed a US patent for the His Tag fusion protein purification technique to Pierce Biotechnology, the organizations said today.

 

The patent, number 4,569,794, is entitled, "Process for purifying proteins and compounds useful in such process," and describes a process in which a precursor of a biologically active protein or polypeptide is separated from a mixture that contains immobilized metal ions. It was granted in 1986 and originally assigned to Eli Lilly, which is one of the partners in Inproteo.

 

The license covers past and future use of the technology over the life of the patent, and "allows Pierce to supply licensed products to their customers for research purposes," said John Hurrell, President of Inproteo, in a statement.

 

Inproteo,  founded in 2002, is a partnership between Indiana University, Purdue University and Eli Lilly that focuses on the development of novel proteomic discovery tools and methods.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.